Question 1

What is Intercept's focus?

Accepted Answer

Intercept's focus is to develop and deliver novel medicines for those living with rare and serious liver diseases.

Question 2

What is primary biliary cholangitis (PBC)?

Accepted Answer

PBC is a rare, progressive, and chronic autoimmune disease that causes bile acid to build up in the liver, resulting in inflammation and scarring (fibrosis), which, if left untreated, can lead to cirrhosis, the need for a liver transplant, or death.

Question 3

What is Intercept's commitment to people living with PBC?

Accepted Answer

Intercept is continuing to deliver the only FDA-approved second-line treatment for people living with PBC and is progressing its research portfolio with a novel fixed-dose combination, aiming to improve the lives of people with PBC.

Question 4

What is Intercept's approach to developing treatments for liver diseases?

Accepted Answer

Intercept is advancing treatments for rare and serious liver diseases by using key discoveries in the field of liver health and focusing on novel scientific targets with the potential for therapeutic application across multiple liver diseases.

Question 5

What is Ally's story?

Accepted Answer

Ally's story highlights how her world was turned upside down when she was diagnosed with PBC, and the importance of getting her liver function tested every few months while taking the medication prescribed by her doctor.

Voyager DB

Contact Research

Chrome Extension

Intercept Pharmaceuticals

Company Overview

Company Name

Address

Website

Phone

Approx. Annual Revenue

Employees

Established

About Intercept Pharmaceuticals

More Companies in California

Frequently Asked Questions about Intercept Pharmaceuticals

What is Intercept's focus?

What is primary biliary cholangitis (PBC)?

What is Intercept's commitment to people living with PBC?

What is Intercept's approach to developing treatments for liver diseases?

What is Ally's story?

Categories

Technologies Used

Social Profiles

Key Decision Makers